Agglutination Methods

Published on 09/02/2015 by admin

Filed under Allergy and Immunology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 15987 times

Agglutination Methods

Principles of Agglutination

Precipitation and agglutination are the visible expression of the aggregation of antigens and antibodies through the formation of a framework in which antigen particles or molecules alternate with antibody molecules (Fig. 10-1). Precipitation is the term for the aggregation of soluble test antigens. Precipitation is the combination of soluble antigen with soluble antibody to produce a visible insoluble complex. Agglutination is the process whereby specific antigens (e.g., red blood cells) aggregate to form larger visible clumps when the corresponding specific antibody is present in the serum.

Artificial carrier particles may be needed to indicate visibly that an antigen-antibody reaction has taken place; examples include latex particles and colloidal charcoal. Cells unrelated to the antigen, such as erythrocytes coated with antigen in a constant amount, can be used as biological carriers. Whole bacterial cells can contain an antigen that will bind with antibodies produced in response to that antigen when it is introduced into the host (Table 10-1).

Table 10-1

Examples of Carriers

Type (Reagent) Type of Assay Principle Result
Latex particles C-reactive protein (CRP) A suspension of polystyrene latex particles of uniform size is coated with the IgG fraction of an antihuman CRP-specific serum. If CRP is present in the serum, an antigen-antibody reaction takes place. This reaction causes a change in the uniform appearance of the latex suspension and a clear agglutination results.
Stabilized sheep erythrocytes sensitized with rabbit gamma globulin suspended in buffer solution Rheumatoid factor (RF) RF acts like antibodies against gamma globulin that acts as the antigen. If gamma globulin is attached to a particular carrier (e.g., RBCs or latex particles), the reaction of RF with gamma globulin becomes a visible agglutination.

image

The quality of test results depends on the following technical factors:

Agglutination tests are easy to perform and, in some cases, are the most sensitive tests currently available. It is important to note that quality results are dependent on the proper training of the person performing the assay and adherence to strict quality control regulations (e.g., positive and negative control sera). Agglutination-type tests have a wide range of applications in the clinical diagnosis of noninfectious immune disorders and infectious disease.

Latex Agglutination

In latex agglutination procedures (Box 10-1), antibody molecules can be bound to the surface of latex beads. Many antibody molecules can be bound to each latex particle, increasing the potential number of exposed antigen-binding sites. If an antigen is present in a test specimen such as C-reactive protein, the antigen will bind to the combining sites of the antibody exposed on the surface of the latex beads, forming visible cross-linked aggregates of latex beads and antigen (Fig. 10-2). In some procedures (e.g., pregnancy testing, rubella antibody testing), latex particles can be coated with antigen. In the presence of serum antibodies, these particles agglutinate into large visible clumps.

Procedures based on latex agglutination must be performed under standardized conditions. The amount of antigen-antibody binding is influenced by factors such as pH, osmolarity, and ionic concentration of the solution. A variety of conditions can produce false-positive or false-negative reactions in agglutination testing (see Table 10-4).

Coagglutination and liposome-enhanced testing are variations of latex agglutination (Fig. 10-3). Coagglutination uses antibodies bound to a particle to enhance the visibility of agglutination. It is a highly specific method but may not be as sensitive as latex agglutination for detecting small quantities of antigen.

Pregnancy Testing

The principle of antigen and antibody interaction has been applied to pregnancy testing since the first agglutination tests were developed in the 1960s. These assays have replaced animal testing.

Human Chorionic Gonadotropin

Pregnancy tests are designed to detect minute amounts of human chorionic gonadotropin (hCG), a glycoprotein hormone secreted by the trophoblast of the developing embryo that rapidly increases in the urine or serum during the early stages of pregnancy.

This glycoprotein hormone consists of two noncovalently linked subunits, alpha (α) and beta (β). The α unit is identical to that found in luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH). The β subunit has a unique carboxy-terminal region. Using antibodies made against the β subunit will cut down on cross-reactivity with the other three hormones. Accordingly, many pregnancy test kits contain monoclonal antibody (MAb) directed against the β subunit to increase the specificity of the reaction.

For the first 6 to 8 weeks after conception, hCG helps maintain the corpus luteum and stimulate the production of progesterone. As a general rule, the level of hCG should double every 2 to 3 days. Pregnant women usually attain serum concentrations of 10 to 50 mIU/mL of hCG in the week after conception. If a test is negative at this stage, the test should be repeated within a week. Peak levels are reached approximately 2 to 3 months after the last menstrual period (LMP).

image Pregnancy Latex Slide Agglutination

Principle

The rapid, direct, monoclonal latex slide agglutination test for detection of hCG is based on the principle of agglutination between latex particles coated with anti-hCG antibodies and hCG, if present, in the test specimen.

See image for the procedural protocol.

Results

False-Positive Results

If a patient has been given an hCG injection (e.g., Pregnyl) to trigger ovulation or lengthen the luteal phase of the menstrual cycle, trace amounts can remain in the patient’s system for as long as 10 days after the last injection. This will produce a false-positive result. Two consecutive quantitative hCG blood assays can circumvent this problem. If the hCG level increases by the second test, the patient is probably pregnant. Chorioepithelioma, hydatidiform mole, or excessive ingestion of aspirin may give false-positive results.

In men, a test identical to that used for pregnancy may be performed to detect the presence of a testicular tumor. If MAb against the β subunit is not used, other hormones with the same α unit may cross-react and cause a false-positive reaction.

Alternate Procedural Protocols

Latex agglutination slide tests have been replaced in many situations (e.g., home testing; see Chapter 9) by one-step chromatographic color-labeled immunoassays for the qualitative detection of hCG in urine (e.g., Clearview hCG II and Clearview hCG Easy, Wampole Laboratories, Princeton, NJ). Another variation is a one-step chromatographic color-labeled immunoassay for use with urine or serum (e.g., Wampole PreVue hCG Stick or Cassette, Status hCG).

Flocculation Tests

Flocculation tests for antibody detection are based on the interaction of soluble antigen with antibody, which results in the formation of a precipitate of fine particles. These particles are macroscopically or microscopically visible only because the precipitated product is forced to remain in a confined space.

Flocculation testing can be used in syphilis serologic testing (see Chapter 18). These tests are the classic Venereal Disease Research Laboratories (VDRL) and rapid plasma reagin (RPR) tests. In the VDRL test, an antibody-like protein, reagin, binds to the test antigen, cardiolipin-lecithin–coated cholesterol particles, and produces the particles that flocculate. In the RPR test, the antigen, cardiolipin-lecithin–coated cholesterol with choline chloride, also contains charcoal particles that allow for macroscopically visible flocculation.

Direct Bacterial Agglutination

Direct agglutination of whole pathogens can be used to detect antibodies directed against the pathogens. The most basic tests measure the antibody produced by the host to antigen determinants on the surface of a bacterial agent in response to infection with that bacterium. In a thick suspension of the bacteria, the binding of specific antibodies to surface antigens of the bacteria causes the bacteria to clump together in visible aggregates. This type of agglutination is called bacterial agglutination.

The formation of aggregates in solution is influenced by electrostatic and other forces; therefore, certain conditions are usually necessary for satisfactory results. The use of sterile physiologic saline with free positive ions in the agglutination procedure enhances the aggregation of bacteria because most bacterial surfaces exhibit a negative charge that causes them to repel each other. Because it allows more time for the antigen-antibody reaction, tube testing is considered more sensitive than slide testing. The small volume of liquid used in slide testing requires rapid reading before the liquid evaporates.

Hemagglutination

The hemagglutination method of testing detects antibodies to erythrocyte antigens. The antibody-containing specimen can be serially diluted and a suspension of red blood cells (RBCs) added to the dilutions. If a sufficient concentration of antibody is present, the erythrocytes are cross-linked and agglutinated. If nonreacting antibody or an insufficient quantity of antibody is present, the erythrocytes will fail to agglutinate.

By binding different antigens to the RBC surface in indirect hemagglutination or passive hemagglutination (PHA), the hemagglutination technique can be extended to detect antibodies to antigens other than those present on the cells (Box 10-2). Chemicals such as chromic chloride, tannic acid, and glutaraldehyde can be used to cross-link antigens to the cells.

Some antibodies (e.g., immunoglobulin G [IgG]) do not directly agglutinate erythrocytes. This incomplete or blocking type of antibody may be detected by using an enhancement medium such as antihuman globulin (AHG) reagent (also known as Coombs reagent). If AHG reagent is added, this second antibody binds to the antibody present on the erythrocytes (see procedure in Chapter 26).

Mechanisms of Agglutination

Agglutination is the clumping of particles that have antigens on their surface, such as erythrocytes, by antibody molecules that form bridges between the antigenic determinants. This is the end point for most tests involving erythrocyte antigens. Agglutination is influenced by a number of factors and is believed to occur in two stages, sensitization and lattice formation.

Sensitization

The first phase of agglutination, sensitization, represents the physical attachment of antibody molecules to antigens on the erythrocyte membrane. The combination of antigen and antibody is a reversible chemical reaction. Altering the physical conditions can result in the release of antibody from the antigen-binding site. When physical conditions are purposely manipulated to break the antigen-antibody complex, with subsequent release of the antibody into the surrounding medium, the procedure is referred to as an elution.

The amount of antibody that will react is affected by the equilibrium constant, or affinity constant, of the antibody. In most cases, the higher the equilibrium constant, the higher is the rate of association and the slower the rate of dissociation of antibody molecules. The degree of association between antigen and antibody is affected by a variety of factors and can be altered in some cases in vitro by altering some of the factors that influence antigen-antibody association, including the following:

Particle Charge

Inert particles such as latex, RBCs, and bacteria have a net negative surface charge called the zeta potential (Fig. 10-4). The concentration of salt in the reaction medium has an effect on antibody uptake by the membrane-bound erythrocyte antigens. Sodium (Na+) and chloride (Cl) ions in a solution have a shielding effect. These ions cluster around and partially neutralize the opposite charges on antigen and antibody molecules, which hinders antibody-antigen association. By reducing the ionic strength of a reaction medium (e.g., using low ionic strength saline [LISS]), antibody uptake is enhanced. Charges can be overcome by centrifugation, addition of charged molecules (e.g., albumin, LISS), or enzyme pretreatment to permit the cross-linking that results in agglutination (Table 10-2).

Table 10-2

Techniques to Reduce Zeta Potential

Technique Action
Enzyme pretreatment of red blood cells Removes negatively charged sialic acid residues from cell surface membrane
Addition of colloids (e.g., albumin) Increases electrical conductivity of environment
Centrifugation Mechanical process to force red blood cells closer together

Adapted from Lehman CA: Saunders manual of clinical laboratory science, Philadelphia, 1998, WB Saunders, p 391.

Antigen-Antibody Ratio

Under conditions of antibody excess, there is a surplus of molecular antigen-combining sites not bound to antigenic determinants. Precipitation reactions depend on a zone of equivalence, the zone in which optimum precipitation occurs, because the number of multivalent sites of antigens and antibodies are approximately equal. For a precipitation reaction to be detectable, the reaction must occur in the zone of equivalence. In this zone, each antibody or antigen binds to more than one antigen or antibody, respectively, forming a stable lattice or network (see later). This lattice hypothesis is based on the assumptions that each antibody molecule must have at least two binding sites and that an antigen must be multivalent.

On either side of the zone of equivalence, precipitation is prevented because of an excess of antigen or antibody. If excessive antibody concentration is present, the phenomenon known as the prozone phenomenon occurs, which can result in a false-negative reaction. In this case, antigen combines with only one or two antibody molecules and no cross-linkages are formed. This phenomenon can be overcome by serially diluting the antibody-containing serum until optimum amounts of antigen and antibody are present in the test system.

If an excess of antigen occurs, the postzone phenomenon occurs, in which small aggregates (clumps) are surrounded by excess antigen and no lattice formation is established. Excess antigen can block the presence of a small amount of antibody. To correct the postzone phenomenon, a repeat blood specimen should be collected 1 or more weeks later. If an active antibody reaction is occurring in vivo, the titer of antibody will increase and should be detectable. Repeated negative results generally suggest that the patient has the specific antibody being tested for by the procedure.

Antigenic Determinants

The placement and number of antigenic determinants both affect agglutination. For example, the A blood group antigen has more than 1.5 million sites/RBC, whereas the Kell blood group antigen has about 3500 to 6000 sites/RBC. If the number of antigenic sites is small or if the antigenic sites are buried deeply in the cell membranes, antibodies will be unable physically to contact antigenic sites.

Steric hindrance is an important physiochemical effect that influences antibody uptake by cell surface antigens. If dissimilar antibodies with approximately the same binding constant are directed against antigenic determinants located close to each other, the antibodies will compete for space in reaching their specific receptor sites. The effect of this competition can be mutual blocking, or steric hindrance, and neither antibody type will be bound to its respective antigenic determinant. Steric hindrance can occur whenever there is a conformational change in the relationship of an antigenic receptor site to the outside surface. In addition to antibody competition, competition with bound complement, other protein molecules, or the action of agents that interfere with the structural integrity of the cell surface can produce steric hindrance.

Methods of Enhancing Agglutination

Techniques used to enhance agglutination include the following:

Treatment with proteolytic enzymes and the use of colloids or AHG techniques could be applied in the immunology laboratory.

Centrifugation attempts to overcome the problem of distance by subjecting sensitized cells to a high gravitational force that counteracts the repulsive effect and physically forces the cells together.

Enzyme treatment alters the zeta potential or dielectric constant to enhance the chances of demonstrable agglutination. Mild proteolytic enzyme treatment can strip off some of the negative charges on the cell membrane by removing surface sialic acid residues (cleaving sialoglycoproteins from the cell surface), which reduces the surface charge of cells, lowers the zeta potential, and permits cells to come closer together for chemical linking by specific antibody molecules.

Some IgG antibodies will agglutinate if the zeta potential is carefully adjusted by the addition of colloids and salts.

In some cases, antigens may be so deeply embedded in the membrane surface that the previous techniques will not bring the antigens and antibodies close enough to cross-link. The AHG test is frequently incorporated into the protocol of many laboratory techniques to facilitate agglutination. The direct AHG test can be used to detect disorders such as hemolytic disease of the newborn, transfusion reactions, and differentiation of immunoglobulin from complement coating of erythrocytes.

Graded Agglutination Reactions

Observation of agglutination is initially made by gently shaking the test tube containing the serum and cells and viewing the lower portion, the button, with a magnifying glass as it is dispersed. Because agglutination is a reversible reaction, the test tube must be treated delicately, and hard shaking must be avoided; however, all the cells in the button must be resuspended before an accurate observation can be determined. Attention should also be given to whether discoloration of the fluid above the cells, the supernatant, is present. Rupture or hemolysis of erythrocytes is as important a finding as agglutination.

The strength of agglutination (Table 10-3; Fig. 10-5), called grading, uses a scale of 0, or negative (no agglutination), to 41 (all erythrocytes clumped). Table 10-4 describes false-positive and false-negative reactions. Pseudoagglutination, or the false appearance of clumping, may rarely occur because of rouleaux formation. Rouleaux formation can be encountered in patients with high or abnormal types of globulins in their blood, such as in multiple myeloma or after receiving dextran as a plasma expander. On microscopic examination, the erythrocytes appear as rolls resembling stacks of coins. To disperse the pseudoagglutination, a few drops of physiologic NaCl (saline) can be added to the reaction tube, remixed, and reexamined. This procedure, saline replacement, should be performed carefully after pseudoagglutination is suspected. It should never be done before the initial testing protocol is followed; a false-negative result may occur from the dilutional effect of the saline.

Table 10-3

Grading Agglutination Reactions

Grade Description
Negative No aggregates
Mixed field A few isolated aggregates; mostly free-floating cells; supernatant appears red
Weak (±) Tiny aggregates barely visible macroscopically; many free erythrocytes; turbid and reddish supernatant
1+ A few small aggregates just visible macroscopically; many free erythrocytes; turbid and reddish supernatant
2+ Medium-sized aggregates; some free erythrocytes; clear supernatant
3+ Several large aggregates; some free erythrocytes; clear supernatant
4+ All erythrocytes are combined into one solid aggregate; clear supernatant.

Table 10-4

Causes of False-Positive and False-Negative Agglutination Test Reactions

Cause Correction
False-Positive Reactions
Contaminated equipment or reagents may cause particles to clump. Store equipment and reagent in clean, dust-free environment, and handle with care.
Use negative quality control (QC) steps.
Autoagglutination Use a control with saline and no antibody as a negative control.
If positive, patient’s result is invalid.
Delay in reading slide reactions results in drying out of mixture. Follow procedural directions and read reactions exactly as specified.
Overcentrifugation causes cells or particles to clump too tightly. Calibrate centrifuge to proper speed and time.
False-Negative Reactions
Inadequate washing of red blood cells in antihuman globulin (AHG) testing may result in unbound immunoglobulins neutralizing the reagent. Wash cells according to directions.
Use positive and negative QC steps.
Failure to add AHG reagent Use positive QC steps.
Contaminated or expired reagents Use positive and negative QC steps.
Improper incubation Follow procedural protocol exactly.
Use positive and negative QC steps.
Delay in reading slide reactions Follow procedural protocol exactly.
Use positive and negative control steps.
Undercentrifugation Calibrate centrifuge to proper speed and time.
Prozone phenomenon Dilute patient serum containing antibody, and repeat the procedure.

image

See Chapter 26.

Microplate Agglutination Reactions

Serologic testing has usually been performed by slide or test tube techniques, but the increased emphasis on cost containment has stimulated interest in microtechniques as an alternative to conventional methods. Micromethods for RBC antigen and antibody testing include hemagglutination and solid-phase adherence assays. These methods are also considered to be easier to perform. The use of microplates allows for the performance of a large number of tests on a single plate, which eliminates time-consuming steps such as labeling test tubes.

A microplate is a compact plate of rigid or flexible plastic with multiple wells. The wells may be U-shaped or have a flat bottom configuration. The U-shaped well has been used most often in immunohematology. The volume capacity of each well is approximately 0.2 mL, which prevents spilling during mixing. Samples and reagents are dispensed with small-bore Pasteur pipettes. These pipettes are recommended because they deliver 0.025 mL, which prevents splashing. After the specimens and reagents are added to the wells, they are mixed by gentle agitation of the plates. The microplate is then centrifuged for an immediate reading.

Countertop or floor model centrifuges are suitable if they are equipped with special rotors that can accommodate microplate centrifuge carriers and are capable of speeds of 400 to 2000 rpm. Smaller plates can be centrifuged in serologic centrifuges with an appropriate adapter.

After centrifugation, the cell buttons are resuspended by gently tapping the microplate or by using a flat-topped mechanical shaker. A shaker provides a more consistent and standard resuspension of the cells than manual tapping. After the cells are resuspended, the wells are examined with an optical aid or over a well-lit surface. A positive reaction will settle in a diffuse uneven button; negative reactions are manifested by a smooth compact button. Detection of weakly positive reactions is enhanced by allowing the RBCs to settle.

image ABO Blood Grouping (Reverse Grouping)

Principle

The reverse (serum) typing procedure to confirm ABO blood grouping is based on the presence or absence of the antibodies, anti-A and anti-B, in serum. If these antibodies are present in serum, agglutination should be demonstrated when the serum is combined with reagent erythrocytes expressing A or B antigens.

Reverse typing is a cross-check for forward typing (see Chapter 2 procedure). Because of the lack of synthesized immunoglobulins in newborn and very young infants, this procedure is not performed on specimens from these patients.

See image for the procedural protocol.

Reporting Results

Agglutination indicates that an antibody specific for the A or B antigen is present in the serum or plasma being tested. Grade all positive reactions.

Reactions of Patient Serum and Reagent Erythrocytes

A1 Cells B Cells Antibody Blood Group
+ + Anti-A and anti-B O
0 + Anti-B A
+ 0 Anti-A B
0 0 Neither AB

image

Biological Sources of Error

If a patient has been recently transfused with non–group-specific blood, mixed-field agglutination may be observed. If large quantities of non–group-specific blood have been transfused, determination of the correct ABO grouping may be impossible.

Discrepancies in forward typing can result from conditions such as weak antigens, altered expression of antigens caused by disease, chimerism, or excessive blood group substances. Excess amounts of blood group–specific soluble substances present in the plasma in certain disorders (e.g., carcinoma of stomach or pancreas) neutralize the reagent anti-A or anti-B, leaving no unbound antibody to react with the patient’s erythrocytes. This excess of blood group–specific substance produces a false-negative or weak reaction in the forward grouping. If the patient’s erythrocytes are washed with saline, the substance should be removed and a correct grouping can be observed.

Incorrect typing can also result from additional antigens, caused by the following:

Discrepancies in serum (reverse) grouping can result from additional or missing antibodies caused by the following:

Causes of weak or missing antibodies include the following:

Chapter Highlights

• Agglutination of particles to which soluble antigen has been adsorbed is a serum method of demonstrating precipitins. Examples of artificial carriers include latex particles and colloidal charcoal. Cells unrelated to the antigen, such as erythrocytes coated with antigen in a constant amount, can be used as biological carriers.

• In latex agglutination procedures, antibody molecules can be bound to the surface of latex beads. If an antigen is present in a test specimen, the antigen will bind to the combining sites of the antibody exposed on the surface of the latex beads, forming visible cross-linked aggregates of latex beads and antigen.

• Flocculation tests for antibody detection are based on the interaction of soluble antigen with antibody, which results in the formation of a precipitate of fine particles.

• Direct bacterial agglutination can be used to detect antibodies directed against pathogens.